» Articles » PMID: 11443005

Human Genetic Adaptation to High Altitude

Overview
Date 2001 Jul 10
PMID 11443005
Citations 109
Authors
Affiliations
Soon will be listed here.
Abstract

Some 140 million persons live permanently at high altitudes (>2500 m) in North, Central and South America, East Africa, and Asia. Reviewed here are recent studies which address the question as to whether genetic adaptation to high altitude has occurred. Common to these studies are the use of the oxygen transport system and the passage of time as organizing principles, and the recognition of the multifaceted ways in which genetic factors can influence physiological processes. They differ in terms of study approach and sources of evidence for judging duration of high altitude residence. Migrant, family set, and admixture study designs have been used for comparisons within populations. These collectively demonstrate the existence of genetic influences on physiological characteristics of oxygen transport. Differences in oxygen transport-related traits between Tibetan, Andean and European populations have been interpreted as having demonstrated the existence of genetic influences on high altitude adaptation but there is not consensus as to which groups are the best-adapted. Part of the controversy lies in the kinds of evidence used to assess duration of high altitude habitation. More other information is needed for a fuller appreciation of duration of residence and also features of population history (genetic drift, gene flow) but existing data are consistent with Tibetans having lived at high altitude longer than the other groups studied. Another issue surrounds usage of the term "adaptation." The definition should be based on evolutionary biology and physiological traits linked to indices of differential fertility and/or mortality. Two examples are developed to illustrate such linkages; intrauterine growth restriction (IUGR) at high altitude and the prevalence of Chronic Mountain Sickness (CMS). Interpopulational as well as intrapopulational variation exists in these conditions which appear linked to characteristics of oxygen transport. Both adversely influence survival and appear to be less severe (IUGR) or less common (CMS) among Tibetans than other groups. Thus available evidence suggest that Tibetans are better adapted. Needed, however, are studies which are better controlled for population ancestry, especially in South America, to determine the extent to which Tibetans differ from Andean highlanders. More precise information is also needed regarding the genetic factors underlying characteristics of oxygen transport. Such studies in Tibetan, Andean and Europeans as well as other high altitude populations offers a promising avenue for clarifying the adaptive value of physiological components of oxygen transport and the extent to which such factors differ among high altitude populations.

Citing Articles

Comparative Analysis of Gene Expression at Sea Level and High Altitude: A Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) Approach.

Alharthi S, Alsubai A, Almalki S, El-Shehawi A, Eldebsy A, Alsoliman A Cureus. 2024; 16(10):e72489.

PMID: 39600785 PMC: 11592035. DOI: 10.7759/cureus.72489.


Altitude illnesses.

Gatterer H, Villafuerte F, Ulrich S, Bhandari S, Keyes L, Burtscher M Nat Rev Dis Primers. 2024; 10(1):43.

PMID: 38902312 DOI: 10.1038/s41572-024-00526-w.


Sex-biased regulatory changes in the placenta of native highlanders contribute to adaptive fetal development.

Yue T, Guo Y, Qi X, Zheng W, Zhang H, Wang B Elife. 2024; 12.

PMID: 38869160 PMC: 11175615. DOI: 10.7554/eLife.89004.


Hypermethylation of BMPR2 and TGF-β Promoter Regions in Tibetan Patients with High-Altitude Polycythemia at Extreme Altitude.

Zhaxi Q, Gesang L, Huang J, Suona Y, Ci B, Danzeng Z Biochem Genet. 2024; .

PMID: 38787494 DOI: 10.1007/s10528-024-10798-2.


Tibetans exhibit lower hemoglobin concentration and decreased heart response to hypoxia during poikilocapnia at intermediate altitude relative to Han Chinese.

Moya E, Yu J, Brown S, Gu W, Lawrence E, Carlson R Front Physiol. 2024; 15():1334874.

PMID: 38784113 PMC: 11112024. DOI: 10.3389/fphys.2024.1334874.